Correlation Between Quantum Genomics and Crossject

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quantum Genomics and Crossject at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantum Genomics and Crossject into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quantum Genomics SA and Crossject, you can compare the effects of market volatilities on Quantum Genomics and Crossject and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantum Genomics with a short position of Crossject. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantum Genomics and Crossject.

Diversification Opportunities for Quantum Genomics and Crossject

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Quantum and Crossject is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Quantum Genomics SA and Crossject in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crossject and Quantum Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantum Genomics SA are associated (or correlated) with Crossject. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crossject has no effect on the direction of Quantum Genomics i.e., Quantum Genomics and Crossject go up and down completely randomly.

Pair Corralation between Quantum Genomics and Crossject

Assuming the 90 days trading horizon Quantum Genomics SA is expected to generate 4.31 times more return on investment than Crossject. However, Quantum Genomics is 4.31 times more volatile than Crossject. It trades about 0.05 of its potential returns per unit of risk. Crossject is currently generating about -0.01 per unit of risk. If you would invest  17.00  in Quantum Genomics SA on September 2, 2024 and sell it today you would lose (9.79) from holding Quantum Genomics SA or give up 57.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.74%
ValuesDaily Returns

Quantum Genomics SA  vs.  Crossject

 Performance 
       Timeline  
Quantum Genomics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Genomics SA are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Quantum Genomics reported solid returns over the last few months and may actually be approaching a breakup point.
Crossject 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Crossject has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Crossject is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Quantum Genomics and Crossject Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quantum Genomics and Crossject

The main advantage of trading using opposite Quantum Genomics and Crossject positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantum Genomics position performs unexpectedly, Crossject can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crossject will offset losses from the drop in Crossject's long position.
The idea behind Quantum Genomics SA and Crossject pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes